Skip to main content

Table 1 Characteristics of the patients

From: Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients

 

Child A

Child B

Child C

Total

n

35

9

10

54

Male/female

26/9

7/2

5/5

38/16

Age

53.0 ± 9.1

54.9 ± 4.6

49.5 ± 9.1

52.6 ± 8.8

Albumin (g/dL)

3.85 ± 0.43

3.12 ± 0.38

2.94 ± 0.57

3.56 ± 0.6

Bilirubin (mg/dL)

0.90 ± 0.43

1.25 ± 0.35

3.09 ± 1.28

1.37± 1.07

ALT (U/L)

118.2 ± 125.5

62.7 ± 43.2

80.6 ± 96.8

102.0 ± 113.0

Platelet (× 104/μL)

11.8 ± 5.3

7.3 ± 3.2

6.3 ± 2.5

10.0 ± 5.2

HBeAg (+/-)

17/18

6/3

6/4

29/25

HBV-DNA (log copies/mL)

    

< 5.0

1

1

2

4

5.0 ≤ x < 7.0

21

4

3

28

≥ 7.0

13

4

5

22